|60.27||-0.87 / -1.42%|
Data as of 5:18pm ET
|60.34||+0.07 / +0.12%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 60.00, with a high estimate of 72.00 and a low estimate of 36.00. The median estimate represents a -0.45% decrease from the last price of 60.27.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.